Showing results (1-10 of 88) with videos related to
Sort By:
Pageof 9
Current Treatment Options in Oncology|August 23, 2025
Updates on Therapy Options in Fit and Unfit Patients with Newly Diagnosed AMLGray H Magee, Michael R GrunwaldJournal of Vascular and Interventional Radiology : JVIR|April 6, 2004
Comparison of urokinase, alteplase, and reteplase for catheter-directed thrombolysis of deep venous thrombosisMichael R Grunwald, Lawrence V HofmannInternational Journal of Hematology|April 25, 2013
FLT3 inhibitors for acute myeloid leukemia: a review of their efficacy and mechanisms of resistanceMichael R Grunwald, Mark J LevisSeminars in Hematology|June 27, 2015
FLT3 Tyrosine Kinase Inhibition as a Paradigm for Targeted Drug Development in Acute Myeloid LeukemiaMichael R Grunwald, Mark J LevisCancer|September 28, 2023
Top advances of the year: Myeloproliferative neoplasmsRupali R Bhave, Ruben Mesa, Michael R GrunwaldLeukemia Research Reports|September 2, 2022
Durable remission of acute myeloid leukemia in an elderly patient following a limited course of azacitidine and venetoclaxHamid Ehsan, Qamar Iqbal, Adeel Masood, et al.Frontiers in Oncology|December 29, 2022
Co-management strategies for acute myeloid leukemia patients in the community settingChristopher Benton, Michael R Grunwald, Hana Safah, et al.Cancer Management and Research|May 23, 2015
Expanding role of lenalidomide in hematologic malignanciesNilanjan Ghosh, Michael R Grunwald, Omotayo Fasan, et al.Seminars in Oncology|May 15, 2016
Cutaneous manifestations in leukemia patientsMichael R Grunwald, Megan H McDonnell, Raghava Induru, et al.Hematology/Oncology and Stem Cell Therapy|October 14, 2015
Use of molecular markers to determine postremission treatment in acute myeloid leukemia with normal cytogeneticsEdward A Copelan, Michael R Grunwald, Lawrence J Druhan, et al.Pageof 9